Evidence map›Paper›PMID 39131718›Full record

ArticleGastro hep advances2024

Ketamine-Induced Sclerosing Cholangitis Associated With Early Inflammatory Bowel Disease During Chronic Topical Ketamine Use.

Gerond Lake-Bakaar, Benjamin Milgrom, Clark Kulig, Andrea K Sotelo, Joselle Speirs, Alexandra Meihofer

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Gastro hep advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gerond Lake-BakaarTransplant Center, Presbyterian St. Luke's Medical Center, Denver, Colorado.
Benjamin MilgromDepartment of Medicine, Presbyterian St. Luke's Medical Center, Denver, Colorado.
Clark KuligTransplant Center, Presbyterian St. Luke's Medical Center, Denver, Colorado.
Andrea K SoteloDepartment of Pathology, Presbyterian St. Luke's Medical Center, Denver, Colorado.
Joselle SpeirsTransplant Center, Presbyterian St. Luke's Medical Center, Denver, Colorado.
Alexandra MeihoferTransplant Center, Presbyterian St. Luke's Medical Center, Denver, Colorado.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ketamine-induced sclerosing cholangitis has been described with chronic intranasal and intravenous use. Our case follows chronic topical use for peripheral neuropathy. It is also uniquely associated with early inflammatory bowel disease, a known complication of primary sclerosing cholangitis.

Indexed as

Drug-Induced Liver InjuryInflammatory Bowel DiseaseKetaminePrimary Sclerosing Cholangitis

Identifiers

PMID39131718
PMCPMC11308429

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.